Abelacimab Clinical Trials (2026): 4 Studies for Atrial Fibrillation (AF) & Deep Venous Thrombosis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
4 Abelacimab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Atrial Fibrillation (AF) & Deep Venous Thrombosis) and 4,754 total planned enrollment. 3 Phase 3 Abelacimab trials and 1 Phase 2 are listed. 1 Abelacimab clinical trial is actively recruiting at 113 U.S. sites across 30 states. Most recent activity: NCT04755283 (Dec 2028).
Where to Participate: All Abelacimab Trial Sites in the U.S. (113 sites across 30 states)
Every actively recruiting Abelacimabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | Anthos Investigational site 9939 | Birmingham35233 | NCT05712200 | Map |
| AL | Anthos Investigative Site 1040 | Birmingham35205 | NCT05712200 | Map |
| AL | Anthos Investigative Site 1041 | Mobile36608 | NCT05712200 | Map |
| AZ | Anthos Investigative Site 1099 | Peoria85381 | NCT05712200 | Map |
| AZ | Anthos Investigative Site 9906 | Phoenix85018 | NCT05712200 | Map |
| AZ | Anthos Investigative Site 9927 | Yuma85365 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9929 | Huntington Beach92648 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9959 | Imperial92251 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9921 | Lancaster93534 | NCT05712200 | Map |
| CA | Anthos Investigative Site 1078 | Loma Linda92357 | NCT05712200 | Map |
| CA | Anthos Investigative Site 1077 | Los Angeles90022 | NCT05712200 | Map |
| CA | Anthos Investigative Site 1071 | San Dimas91773 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9938 | Santa Rosa95405 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9908 | South Gate90280 | NCT05712200 | Map |
| CA | Anthos Investigative Site 9907 | Vista92081 | NCT05712200 | Map |
| CO | Anthos Investigative Site 1095 | Aurora80045 | NCT05712200 | Map |
| CO | Anthos Investigative Site 9922 | Golden80228 | NCT05712200 | Map |
| CT | Anthos Investigative Site 1012 | Stamford06905 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9934 | Altamonte Springs32714 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1013 | Boca Raton33486 | NCT05712200 | Map |
| FL | Anthos Investigational site 9810 | Bradenton34209 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1022 | Clearwater33777 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1025 | Clearwater33756 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1019 | Daytona Beach32114 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9936 | Hialeah33012 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1083 | Hollywood33024 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9804 | Hollywood33020 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9904 | Lake Mary32746 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1093 | Lutz33558 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9933 | Miami33145 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9940 | Ocala34474 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9944 | Ocala34471 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1026 | Safety Harbor34695 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1002 | Saint Augustine32086 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1004 | Saint Augustine32086 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1044 | Tamarac33321 | NCT05712200 | Map |
| FL | Anthos Investigative Site 1088 | Tamarac33321 | NCT05712200 | Map |
| FL | Anthos Investigative Site 9911 | The Villages32162 | NCT05712200 | Map |
| GA | Anthos Investigative Site 1033 | Macon31201 | NCT05712200 | Map |
| GA | Anthos Investigative Site 1003 | Suwanee30024 | NCT05712200 | Map |
| GA | Anthos Investigative Site 9953 | Tucker30084 | NCT05712200 | Map |
| IL | Anthos Investigative Site 1030 | Park Ridge60068 | NCT05712200 | Map |
| IL | Anthos Investigative Site 9932 | Rockford61107 | NCT05712200 | Map |
| IL | Anthos Investigative Site 9925 | Winfield60190 | NCT05712200 | Map |
| IN | Anthos Investigative Site 9915 | Evansville47714 | NCT05712200 | Map |
| IN | Anthos Investigative Site 1098 | Merrillville46410 | NCT05712200 | Map |
| IA | Anthos Investigative Site 9956 | West Des Moines50266 | NCT05712200 | Map |
| KS | Anthos Investigative Site 9958 | Hutchinson67502 | NCT05712200 | Map |
| KS | Anthos Investigative Site 1016 | Wichita67207 | NCT05712200 | Map |
| LA | Anthos Investigative Site 1043 | Shreveport71103 | NCT05712200 | Map |
| LA | Anthos Investigational site 9803 | West Monroe71291 | NCT05712200 | Map |
| ME | Anthos Investigative Site 1054 | Bangor04401 | NCT05712200 | Map |
| MD | Anthos Investigative Site 1039 | Baltimore21218 | NCT05712200 | Map |
| MD | Anthos Investigative Site 9957 | Baltimore21229 | NCT05712200 | Map |
| MD | Anthos Investigative Site 1023 | Lanham20746 | NCT05712200 | Map |
| MD | Anthos Investigational site 9962 | Rockville20850 | NCT05712200 | Map |
| MA | Anthos Investigative Site 9918 | Boston02215 | NCT05712200 | Map |
| MI | Anthos Investigative Site 1021 | Lansing48912 | NCT05712200 | Map |
| MI | Anthos Investigative Site 9946 | Petoskey49770 | NCT05712200 | Map |
| MI | Anthos Investigative Site 1059 | Southgate48195 | NCT05712200 | Map |
| MO | Anthos Investigative Site 1080 | Kansa City64151 | NCT05712200 | — |
| MO | Anthos Investigative Site 9948 | Kansas City64114 | NCT05712200 | Map |
| NE | Anthos Investigative Site 1066 | Lincoln68506 | NCT05712200 | Map |
| NV | Anthos Investigative Site 9914 | Las Vegas89123 | NCT05712200 | Map |
| NJ | Anthos Investigative Site 1094 | Englewood07631 | NCT05712200 | Map |
| NY | Anthos Investigative Site 9931 | Albany12211 | NCT05712200 | Map |
| NY | Anthos Investigative Site 9905 | Brooklyn11217 | NCT05712200 | Map |
| NY | Anthos Investigative Site 1037 | Rosedale11422 | NCT05712200 | Map |
| NY | Anthos Investigative Site 9935 | Stony Brook11794 | NCT05712200 | Map |
| NY | Anthos Investigative Site 9920 | Valhalla10595 | NCT05712200 | Map |
| NY | Anthos Investigative Site 9924 | Westfield14787 | NCT05712200 | Map |
| NC | Anthos Investigative Site 1065 | Cary27518 | NCT05712200 | Map |
| NC | Anthos Investigative Site 1005 | Charlotte28207 | NCT05712200 | Map |
| NC | Anthos Investigative Site 9912 | Durham27709 | NCT05712200 | Map |
| NC | Anthos Investigative Site 9950 | Pinehurst28374 | NCT05712200 | Map |
| NC | Anthos Investigative Site 9951 | Statesville28677 | NCT05712200 | Map |
| NC | Anthos Investigative Site 9952 | Wilmington28401 | NCT05712200 | Map |
| OH | Anthos Investigative Site 9902 | Beavercreek45431 | NCT05712200 | Map |
| OH | Anthos Investigative Site 9945 | Dayton45429 | NCT05712200 | Map |
| OK | Anthos Investigative Site 9917 | Oklahoma City73104 | NCT05712200 | Map |
| OR | Anthos Investigative Site 1075 | Portland97239 | NCT05712200 | Map |
| PA | Anthos Investigative Site 1087 | Horsham19044 | NCT05712200 | Map |
| TN | Anthos Investigational site 9954 | Chattanooga37403 | NCT05712200 | Map |
| TN | Anthos Investigative Site 9941 | Jefferson City37760 | NCT05712200 | Map |
| TN | Anthos Investigative Site 1056 | Memphis38128 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9928 | Allen75013 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9913 | Beaumont77702 | NCT05712200 | Map |
| TX | Anthos Investigational site 9967 | Bryan77802 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9942 | Dallas75254 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9943 | Dallas75243 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1091 | El Paso79905 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9930 | Greenville75401 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1064 | Houston77084 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1068 | Houston77025 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1097 | Houston77055 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9903 | Houston77070 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1063 | McAllen78503 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1079 | McKinney75071 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1096 | McKinney75069 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1024 | Odessa79761 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1085 | Port Arthur77642 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9923 | Sherman75090 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1090 | Sugar Land77479 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9916 | Tyler75701 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9910 | Victoria77901 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1060 | Waco76712 | NCT05712200 | Map |
| TX | Anthos Investigative Site 9909 | Webster77598 | NCT05712200 | Map |
| TX | Anthos Investigative Site 1092 | Wylie75098 | NCT05712200 | Map |
| VA | Anthos Investigative Site 1018 | Falls Church22042 | NCT05712200 | Map |
| VA | Anthos Investigative Site 1009 | Roanoke24014 | NCT05712200 | Map |
| VA | Anthos Investigative Site 9949 | Vienna22182 | NCT05712200 | Map |
| WA | Anthos Investigative Site 9926 | Redmond98052 | NCT05712200 | Map |
| WA | Anthos Investigative Site 1073 | Tacoma98405 | NCT05712200 | Map |
Abelacimab clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | terminated | Total |
|---|---|---|---|---|
| P2 | 1 | 1 | ||
| P3 | 1 | 2 | 3 |
Recruiting Abelacimab clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT05712200 | LILAC-TIMI 76Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) | P3 | Atrial Fibrillation (AF) | 1,900 | Dec 2022 |
Abelacimab clinical trials by indication
Atrial Fibrillation (AF) (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04755283 | AZALEA-TIMI 71 | P2 | active not recruiting | Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation |
| NCT05712200 | LILAC-TIMI 76 | P3 | recruiting | Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) |
Venous Thromboembolism (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05171075 | MAGNOLIA | P3 | terminated | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE |
| NCT05171049 | ASTER | P3 | terminated | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE |
Abelacimab pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| LILAC-TIMI 76 | NCT05712200 | P3 | recruiting | Atrial Fibrillation (AF) | 1,900 | PMID 39094433 |
| MAGNOLIA | NCT05171075 | P3 | terminated | Venous Thromboembolism | 417 | — |
| ASTER | NCT05171049 | P3 | terminated | Venous Thromboembolism | 1,150 | — |
| AZALEA-TIMI 71 | NCT04755283 | P2 | active not recruiting | Atrial Fibrillation (AF) | 1,287 | PMID 39842011 |
Terminated and withdrawn Abelacimab trials (2)
Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.
- NCT05171075terminatedA Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- NCT05171049terminatedA Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
All Abelacimab trials (4)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04755283 | AZALEA-TIMI 71 | Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation | P2 | active not recruiting | 1,287 | Anthos Therapeutics, Inc. | Feb 2021 |
| NCT05712200 | LILAC-TIMI 76 | Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) | P3 | recruiting | 1,900 | Anthos Therapeutics, Inc. | Dec 2022 |
| NCT05171075 | MAGNOLIA | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | P3 | terminated | 417 | Anthos Therapeutics, Inc. | Sep 2022 |
| NCT05171049 | ASTER | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | P3 | terminated | 1,150 | Anthos Therapeutics, Inc. | May 2022 |
Abelacimab clinical trials: frequently asked questions
- How many Abelacimab clinical trials are there?
- 4 Abelacimab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Abelacimab clinical trials recruiting in 2026?
- Yes — 1 Abelacimab trial is actively recruiting in 2026, with 113 U.S. sites across 30 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Abelacimab being studied for?
- Abelacimab is being studied for Atrial Fibrillation (AF), Deep Venous Thrombosis, Pulmonary Embolism, Venous Thromboembolism, Stroke. The trials are grouped by indication on this page.
- What phase is Abelacimab in?
- Abelacimab clinical trials span 3 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Abelacimab clinical trials?
- The lead sponsor across the most Abelacimab trials is Anthos Therapeutics, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Abelacimabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: